-+ 0.00%
-+ 0.00%
-+ 0.00%

US FDA - EXPANDS INDICATION FOR NOGAPENDEKIN ALFA INBAKICEPT-PMLN TO HIGH-GRADE PAPILLARY-ONLY NMIBC

Reuters·10/14/2026 15:23:05